Measurement of the quality of life during different clinical phases of breast cancer

Journal of the Formosan Medical Association

Volumn 98, Issue 4, 1999, Pages 254-260

  Chie, Wei Chu ^a   Huang, Chiun Sheng ^b   Chen, Jen Hau ^a   Chang, King Jen ^b,c  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Quality of life breast cancer chemotherapy

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER STAGING; COGNITION; EMOTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PHYSICAL PERFORMANCE; QUALITY OF LIFE; QUESTIONNAIRE; SOCIAL INTERACTION;

ADULT; AGED; BREAST NEOPLASMS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 0032982219     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Chie WC, Chen CF, Lee WC, et al: Age-period-cohort analysis of breast cancer mortality. Anticancer Res 1995;15: 511-6.
2. Winer EP: Quality-of-life research in patients with breast cancer. Cancer 1994;74:410-5.
3. Fallowfield LJ: Assessment of quality of life in breast cancer. Acta Oncologica 1995;34:689-94.
4. Guyatt GH, Jaeschke R, Feeny DH, et al: Measurements in clinical trials: choosing the right approach. In: Spilker B, ed. Quality of Life and Pharmacoeconomics in Clinical Trials. 2nd ed. Philadelphia: Lippincott-Raven Publishers 1996: 41-8.
5. Ware JE, Kosinski M, Keller SD: SF-36 Physical and Mental Health Summary Scales: A User's Manual. Boston: The Health Institute, New England Medical Center, 1994.
6. Ganz PA, Day R, Ware JE, et al: Base-line quality-of-life assessment in the national surgical adjuvant breast and bowel project breast cancer prevention trial. J Natl Cancer Inst 1995;87:1372-82.
7. Hann DM, Jacobsen PB, Martin SC, et al: Quality of life following bone marrow transplantation for breast cancer: a comparative study. Bone Marrow Transplant 1997;19:257-64.
8. Aronson NK, Ahmedzai S, Bergman B, et al: The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365-76.
9. King MT, Dobson AJ, Harnett PR: A comparison of two quality-of-life questionnaires for cancer clinical trials: the Functional Living Index - Cancer (FLIC) and the Quality of Life Questionnaire Core Module (QLQ-C30). J Clin Epidemiol 1996;49:21-9.
10. Groenvold M, Klee MC, Sprangers MAG, et al: Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patients - observer agreement. J Clin Epidemiol 1997;50:441-5.
11. New England Medical Center Hospital: IQOLA SF-36 Taiwan Standard Version 1.0. Boston: The Health Institute, New England Medical Center, 1996.
12. EORTC Quality of Life Study Group: Questionnaire of the Department of Obstetrics and Gynecology, Hong Kong University (EORTC QLQ-C30 version 2.0). Brussels: Quality of Life Unit, EORTC Data Center, 1997.
13. Drummond MF, Stoddart GL, Torrance GW: Cost-utility analysis. In: Drummond MF, Stoddart GL, Torrance GW, eds. Methods for the Economic Evaluation of Health Care Programmes. Oxford: Oxford University Press, 1987: 112-48.
14. Patrick DL, Erickson P: Assigning values to health status. In: Patrick DL, Erickson P, eds. Health Status and Health Policy, Quality of Life in Health Care Evaluation and Resource Allocation. Oxford: Oxford University Press, 1993: 143-80.
15. Bennett KJ, Torrance GW: Measuring health state preferences and utilities: rating scale, time trade-off, and standard gamble techniques. In: Spilker B, ed. Quality of Life and Pharmacoeconomics in Clinical Trials. 2nd ed. Philadelphia: Lippincott-Raven Publishers, 1996:253-65.
16. de Haes JCJM, de Koning HJ, van Oortmarssen GJ, et al: The impact of breast cancer screening programme on quality-adjusted life-years. Int J Cancer 1991;49:538-44.
17. Hall J, Gerard K, Salkeld G, et al: A cost utility analysis of mammography screening in Australia. Soc Sci Med 1992;34:993-1004.
18. Gerard K, Dobson M, Hall J: Framing and labeling effects in health descriptions: quality adjusted life years for treatment of breast cancer. J Clin Epidemiol 1993;46: 77-84.
19. Hochberg Y, Benjamin Y. More powerful procedures for multiple significance testing. Stat Med 1990;9:811-8.
20. White GM: The role of cultural explanations in 'somatization' and 'psychologization'. Soc Sci Med 1982; 16:1519-30.
21. Zheng YP, Xu LY, Shen QJ: Styles of verbal expression of emotional and physical expressions: a study of depressed patients and normal controls in China. Cult Med Psychiatry 1986;10:231-43.
22. Cheng TA: Symptomatology of minor psychiatric morbidity: a cross-cultural comparison. Psychol Med 1989; 19:697-708.
23. Chang C, Huang MK, Lin HC: A pilot study of stress and coping of breast cancer patients. Journal of the National Public Health Association 1988;8:109-24. [In Chinese].
24. Alagaratnam TT, Kung NYT: Psychosocial effects of mastectomy: is it due to mastectomy or to the diagnosis of malignancy? Br J Psychiatry 1986;149:296-9.